Feedback Share Discussion Threads

[ragnarr] 13/12/2021 12:00

LR2 / Ged - thank youpotential linksMedanta collaborates with Qure.ai to enhance analysis of chest illnesseshttps://aajkitaazanews.com/medanta-collaborates-with-qure-ai-to-enhance-analysis-of-chest-illnesses-297/.https://www.medanta.org/about/

[ragnarr] 13/12/2021 11:01

India's plan to eliminate tuberculosis by 2025: converting rhetoric into realityhttps://gh.bmj.com/content/2/2/e000326

[yump] 13/12/2021 10:51

So better and quicker tech is being sold at 1/10th of the previous cost ?

Presumably that is a cost that makes mass testing viable, when it wasn’t before. Otherwise its an odd commercial decision.

Anyone see that in the various presentations ? May have missed it. Has the Indian gov committed to testing if the overall cost makes it possible ?

[ged5] 13/12/2021 10:37

Thanks:

2.6m every year.



"at the minute TB screening studies are typically charged at about 2000- 2500 rupees per screening episode, which is about 20-25 pounds , now we can provide our technology suite into that space for £2.00 at a 80 percent EBITDA margin, so 90 percent gross plus margin, and that will allow us to essentially to really scale that technology with our partners, clinical partners on the ground in India" Tom Oakley 7th November 2021

[yump] 13/12/2021 10:34

Put it this way - I could do a good Scrooge ;-)

[ragnarr] 13/12/2021 10:24

https://pharmaphorum.com/news/amazon-backs-feedbacks-cloud-screening-project-for-tb-in-india/

[ragnarr] 13/12/2021 10:02

Yump - is it the thought of Christmas thats making you grumpy :-)Health data cannot be fragmented and inaccessible. Modi govt needs a policy revamp.https://theprint.in/opinion/health-data-cannot-be-fragmented-and-inaccessible-modi-govt-needs-a-policy-revamp/778369/

[yump] 13/12/2021 09:39

Think its going to take some decent NHS news to give this any permanent rerating. Somebody sign something with a £ sign involved. Anything.

Theres a mass of shares in good profit below 1p - those potential sellers need to see something that makes them worry about selling.

A wait until well into next year I reckon.

If I hear “watch this space” again and then nothing significant turns up, I’ll be tempted to urge TO to insert Bleepa where the sun don’t shine.

[ged5] 13/12/2021 09:25

The TB screening solution will see X-ray images acquired in rural communities pushed by Feedback's Bleepa Box straight to the cloud to be processed by clinical and artificial intelligence ("AI") partners

Interesting article by the co-founder of Qure.AI in the FT.

[yump] 13/12/2021 09:16

Its a loss-leader for AWS.

[ged5] 13/12/2021 09:12

The Amazon Web Services (AWS) Diagnostic Development Initiative (DDI) is a two-year, $20M commitment to accelerate research and innovation to advance the collective understanding and detection of COVID-19 and other infectious diseases in order to mitigate current and future outbreaks. AWS is offering AWS Promotional Credits and technical expertise to support the use of AWS services for projects by selected institutions and companies in four program areas: early disease detection, diagnostics, prognosis, and public health genomics.

[philjeans] 13/12/2021 08:20

Excellent news.

AWS More cash than they know what to do with!

[david gruen] 13/12/2021 07:51

Looks like virtue signaling by AWS.

[petekand] 13/12/2021 07:49

Amazon has seen the potential!
Any ramping welcome and justified.

[paleje] 13/12/2021 07:48

Potentially definitely. Couldn't see the amount of funding.

[petekand] 13/12/2021 07:39

Surely, this is big news.

[lr2] 13/12/2021 07:05

Feedback receives funding from Amazon Web Services in support of its cloud-based tuberculosis screening programme for rural communities in India

[ragnarr] 12/12/2021 21:47

Actually it would not be a surprise if Royal Papworth were looking at other PACS - but hopefully would Bleepa still be utilised as it is an add on tech..From the finals.Legacy productsAs previously reported TexRAD sales have continued to decline in line with expectations, and in line with our strategy we have reduced the resourcing of this product to a minimum. Cadran continues to be employed in current contracts across a number of trusts, however, with the focus turning towards cloud-based services, we anticipate a slowdown in these contracts in the future. Bleepa and CareLocker have evolved from these high-quality legacy products and as business continues to move to more cloud-based systems, we are confident that Bleepa and CareLocker offer pioneering digital solutions.

[yump] 12/12/2021 17:30

Does anyone think that NHS procurement generally follows the law of entropy, in that disorder tends to increase as time passes.

Thats what it seems like.

O/T The purpose of NICE seems to be to create employment for pen-pushers, as I can’t remember anything that’s been widely implemented even with a glowing approval from them.

I hope they never get asked to look at Bleepa, that would be the kissbof death.

[ragnarr] 12/12/2021 17:05

It would be quite a big thing to have replaced the whole PACS as they have been in partnership with FDBK for some time now and If they had replaced it there would almost certainly be some announcement from the new system supplier - but I cant find anything anywhere.I am actually thinking this could be a positive sign. Bearing in mind all the recent political NHS changes regarding the new digital procurement responsibilities, Royal Papworth is under the jurisdiction of Cambridgeshire and Peterborough Integrated Care System (ICS) so any renewals of digital contracts could well be undergoing due diligence for the wider Care system. Pure speculation obviously.

[ducatiman] 12/12/2021 16:17

It would seem that Papworth has not renewed Cadran.
So what are they using now?

[chopper harris1] 12/12/2021 16:12

Okay, thanks for all that, ragnarr.

Possibly explains why she’s never come across it.

[ragnarr] 12/12/2021 15:58

Chopper - All the best I - you should be in good hands at Addenbrookes.Your comment re Royal Papeorth got me thinking. Bleepa was an upgrade on the renewed contract for Cadran PACS in March 2020. The contract was for 14 months therefore which was an odd timescale but all to do with relocation I think - but that contract would have expired May 2021and I cannot see any official update of the current situation.